Allergy Asthma Respir Dis.
2023 Apr;11(2):56-62. 10.4168/aard.2023.11.2.56.
Report on the methacholine bronchial provocation test protocol: An updated statement of Korean Academy of Asthma, Allergy and Clinical Immunology
- Affiliations
-
- 1Division of Pulmonology and Allergy, Department of Internal Medicine, KyungHee University Medical Center, Seoul, Korea
- 2Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, Korea
- 3Division of Pulmonology, Allergy and Critical Care Medicine, Department of Internal Medicine, Korea University Anam Hospital, Seoul, Korea
- 4Division of Pulmonary, Allergy, and Critical Care Medicine, Hallym University Sacred Heart Hospital, Hallym University College of Medicine, Anyang, Korea
- 5Division of Pulmonology and Allergy, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Korea
- 6Division of Allergy and Immunology, Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea
- 7Department of Pediatrics and Respiratory Disease Center, Chungbuk National University Hospital, Cheongju, Korea
- 8Department of Pediatrics, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Korea
- 9Department of Internal Medicine, Inje University Ilsan Paik Hospital, Goyang, Korea
- 10Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea
- KMID: 2541969
- DOI: http://doi.org/10.4168/aard.2023.11.2.56
Abstract
- The Korean Academy of Asthma, Allergy, and Clinical Immunology task force report aims to provide new protocols for methacholine challenge test (MCT). Although new devices have different delivery system compared to old ones, previous protocols are still used, which cannot guarantee adequate diagnoses of asthma. Another important issue is the recent recommendation in European Respiratory Society (ERS) technical standard guideline to use a delivered methacholine dose that causes a 20% decrease in forced expiratory volume in 1 second (FEV1) (PD 20). Although the previous protocol based on the methacholine concentration causing a 20% decrease in FEV1 (PC 20) has been used globally, several studies have reported that PD 20 is more reliable and applicable for new protocols of MCT. Indeed, a tidal breathing inhalation protocol using a breath-actuated or continuous nebulizer is recommended. Herein, we recommend 3 protocols for the MCT using new devices and provide a brief summary of the change in strategy based on the updated ERS guideline.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Bronchial Asthma with Negative Methacholine Challenge Test
- Clinical Characteristics of Asthmatics Having Negative Results to Methacholine Bronchial Challenge Test
- Clinical consideration of the methacholine bronchial provocation test
- Chronic cough in children:positive rates and provocated symptoms of methacholine bronchial provocation test
- A Case of Cow Hair-Induced Asthma in a Child Living in a Cow Raising Farm
